CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Pharma Startups (6570)
Vigene Biosciences is focused on viral vector production and development, specializing in viral vector-based gene delivery for life science research, gene therapy, and cell therapy purposes. Vigene offers AAV, lentivirus, and adenovirus-based product...Show all
Company (Alive / Active)
Phone: 301-251-6638
5 Research Court
Rockville, 20850
Maryland, United States
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Investor | Investor Type | Location | Participating Rounds |
|---|
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Use of ion concentrations to increase the packaging efficiency of recombinant adeno-associated virus | Jul 15, 2019 | Oct 13, 2020 | Patent |
| Recombinantly-modified adeno-associated virus (raav) having improved packaging efficiency | Jul 15, 2019 | May 19, 2020 | Patent |
| Recombinantly-modified adeno-associated virus helper vectors and their use to improve the packaging efficiency of recombinantly-modified adeno-associated virus | Jul 15, 2019 | Feb 11, 2020 | Patent |
| Recombinantly-modified adeno-associated virus helper vectors and their use to improve the packaging efficiency of recombinantly-modified adeno-associated virus | Dec 06, 2019 | Application |
